awmsg logo



doxycycline (Adjusan®)


Reference No. 2336

Publication date:
13/12/2013


Appraisal information

doxycycline (Adjusan®) 140 mg/g periodontal gel


Company: Heraeus Kulzer Ltd
BNF category: Ear, nose and oropharynx
NMG meeting date: Not scheduled
AWMSG meeting date: Not scheduled
   
   
Submission Type: Nonsubmission
Status: Not endorsed
Advice No: Not available
Ratification by Welsh Government: 06/12/2013

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ratification by
Welsh Government

AWMSG advice

In the absence of a submission from the holder of the marketing authorisation, doxycycline (Adjusan®) cannot be endorsed for use within NHS Wales for the treatment of chronic and aggressive periodontitis with a pocket depth of ≥ 5 mm in adults as an adjunct to conventional non-surgical treatment of periodontitis. Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Statement of Advice (SOA)
Download